OCUGEN, INC. Variable Lease, Cost
OCUGEN, INC. (OCGN) reported Variable Lease, Cost of $480.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-03-04
- OCUGEN, INC. variable lease, cost for the quarter ending 2022-12-31 was $69.00K, a 165.38% increase year-over-year.
- OCUGEN, INC. variable lease, cost for the quarter ending 2022-09-30 was $36.00K, a 38.46% increase year-over-year.
- OCUGEN, INC. variable lease, cost for the quarter ending 2022-06-30 was $26.00K, a 18.18% increase year-over-year.
- OCUGEN, INC. variable lease, cost for the quarter ending 2022-03-31 was $28.00K, a 6.67% decline year-over-year.
- OCUGEN, INC. variable lease, cost for fiscal 2025 was $480.00K, a 35.21% increase from fiscal 2024.
- OCUGEN, INC. variable lease, cost for fiscal 2024 was $355.00K, a 3.80% increase from fiscal 2023.
- OCUGEN, INC. variable lease, cost for fiscal 2023 was $342.00K, a 116.46% increase from fiscal 2022.
- OCUGEN, INC. variable lease, cost for fiscal 2022 was $158.00K, a 50.48% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 6 month as first filed | Variable Lease, Cost 9 month | Variable Lease, Cost 9 month as first filed | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $480.00K 10-K · filed 2026-03-04 | |||||||
| 2024-12-31 | $355.00K 10-K · filed 2026-03-04 | |||||||
| 2023-12-31 | $342.00K 10-K · filed 2025-03-05 | |||||||
| 2022-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $105.00K derived: sum of 2 quarters · filed 2024-04-16 | $131.00K derived: sum of 3 quarters · filed 2024-04-16 | $158.00K 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | $36.00K 10-Q · filed 2022-11-08 | $62.00K derived: sum of 2 quarters · filed 2022-11-08 | $89.00K 10-Q · filed 2022-11-08 | $116.00K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2022-06-30 | $26.00K 10-Q · filed 2022-08-05 | $53.00K 10-Q · filed 2022-08-05 | $80.00K derived: sum of 3 quarters · filed 2023-02-28 | $106.00K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2022-03-31 | $28.00K 10-Q · filed 2022-05-06 | $54.00K derived: sum of 2 quarters · filed 2023-02-28 | $80.00K derived: sum of 3 quarters · filed 2023-02-28 | $102.00K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $52.00K derived: sum of 2 quarters · filed 2023-02-28 | $74.00K derived: sum of 3 quarters · filed 2023-02-28 | $105.00K 10-K · filed 2023-02-28 | ||||
| 2021-09-30 | $26.00K 10-Q · filed 2022-11-08 | $48.00K derived: sum of 2 quarters · filed 2022-11-08 | $79.00K 10-Q · filed 2022-11-08 | $101.00K derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $22.00K 10-Q · filed 2022-08-05 | $52.00K 10-Q · filed 2022-08-05 | $75.00K derived: sum of 3 quarters · filed 2022-08-05 | $96.00K derived: sum of 4 quarters · filed 2022-08-05 | ||||
| 2021-03-31 | $30.00K 10-Q · filed 2022-05-06 | $53.00K derived: sum of 2 quarters · filed 2022-05-06 | $74.00K derived: sum of 3 quarters · filed 2022-05-06 | $94.00K derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2020-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $44.00K derived: sum of 2 quarters · filed 2022-02-28 | $64.00K derived: sum of 3 quarters · filed 2022-02-28 | $85.00K 10-K · filed 2022-02-28 | $84.79K 10-K · filed 2021-03-19 | |||
| 2020-09-30 | $21.00K 10-Q · filed 2021-11-09 | $21.17K 10-Q · filed 2020-11-06 | $41.00K derived: sum of 2 quarters · filed 2021-11-09 | $62.00K 10-Q · filed 2021-11-09 | $62.41K 10-Q · filed 2020-11-06 | $83.84K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | $20.00K 10-Q · filed 2021-08-06 | $20.08K 10-Q · filed 2020-08-14 | $42.00K 10-Q · filed 2021-08-06 | $41.25K 10-Q · filed 2020-08-14 | $62.84K derived: sum of 3 quarters · filed 2022-02-28 | $84.12K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | $21.00K 10-Q · filed 2021-05-07 | $21.17K 10-Q · filed 2020-05-08 | $42.84K derived: sum of 2 quarters · filed 2022-02-28 | $64.12K derived: sum of 3 quarters · filed 2022-02-28 | $85.15K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $21.84K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $43.12K derived: sum of 2 quarters · filed 2022-02-28 | $64.15K derived: sum of 3 quarters · filed 2022-02-28 | $80.00K 10-K · filed 2022-02-28 | $79.70K 10-K · filed 2020-03-27 | |||
| 2019-09-30 | $21.28K 10-Q · filed 2020-11-06 | $42.31K derived: sum of 2 quarters · filed 2020-11-06 | $58.16K 10-Q · filed 2020-11-06 | |||||
| 2019-06-30 | $21.03K 10-Q · filed 2020-08-14 | $36.88K 10-Q · filed 2020-08-14 | ||||||
| 2019-03-31 | $15.85K 10-Q · filed 2020-05-08 | |||||||
| 2018-06-30 | $36.88K 8-K/A · filed 2019-10-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |